NcRNA Regulated Pyroptosis in Liver Diseases and Traditional Chinese Medicine Intervention: A Narrative Review

References

• Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology. 2014;60(6):2099–2108. doi:10.1002/hep.27406
   PubMed Web of Science ®Google Scholar
• Xiao J, Wang F, Wong NK, et al. Global liver disease burdens and research trends: analysis from a Chinese perspective. J Hepatol. 2019;71(1):212–221. doi:10.1016/j.jhep.2019.03.004
   PubMed Web of Science ®Google Scholar
• Zhu J, Wang P, Ye H, et al. Trend of the mortality of major liver diseases and its impact on life expectancy in China from 2006 to 2017. J Public Health (Oxf). 2022;44(1):100–110. doi:10.1093/pubmed/fdaa261
   PubMed Web of Science ®Google Scholar
• Sato K, Kennedy L, Liangpunsakul S, et al. Intercellular Communication between Hepatic Cells in Liver Diseases. Int J Mol Sci. 2019;20(9). doi:10.3390/ijms20092180
   Web of Science ®Google Scholar
• Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun. 2005;73(4):1907–1916. doi:10.1128/IAI.73.4.1907-1916.2005
   PubMed Web of Science ®Google Scholar
• Wree A, Holtmann TM, Inzaugarat ME, Feldstein AE. Novel Drivers of the Inflammatory Response in Liver Injury and Fibrosis. Semin Liver Dis. 2019;39(3):275–282. doi:10.1055/s-0039-1685515
   PubMed Web of Science ®Google Scholar
• DiPeso L, Ji DX, Vance RE, Price JV. Cell death and cell lysis are separable events during pyroptosis. Cell Death Discov. 2017;3:17070. doi:10.1038/cddiscovery.2017.70
   PubMed Web of Science ®Google Scholar
• Wang F, Gómez-Sintes R, Boya P. Lysosomal membrane permeabilization and cell death. Traffic. 2018;19(12):918–931. doi:10.1111/tra.12613
   PubMed Web of Science ®Google Scholar
• Guo H, Xie M, Zhou C, Zheng M. The relevance of pyroptosis in the pathogenesis of liver diseases. Life Sci. 2019;223:69–73. doi:10.1016/j.lfs.2019.02.060
   PubMed Web of Science ®Google Scholar
• Broz P, Pelegrín P, Shao F. The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2020;20(3):143–157. doi:10.1038/s41577-019-0228-2
   PubMed Web of Science ®Google Scholar
• Man SM, Karki R, Kanneganti TD. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev. 2017;277(1):61–75. doi:10.1111/imr.12534
   PubMed Web of Science ®Google Scholar
• Sun P, Zhong J, Liao H, et al. Hepatocytes Are Resistant to Cell Death From Canonical and Non-Canonical Inflammasome-Activated Pyroptosis. Cell Mol Gastroenterol Hepatol. 2022;13(3):739–757. doi:10.1016/j.jcmgh.2021.11.009
   PubMed Web of Science ®Google Scholar
• Al Mamun A, Wu Y, Jia C, et al. Role of pyroptosis in liver diseases. Int Immunopharmacol. 2020;84:106489. doi:10.1016/j.intimp.2020.106489
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu X, Lin C, et al. Noncoding RNAs regulate alternative splicing in Cancer. J Exp Clin Cancer Res. 2021;40(1):11. doi:10.1186/s13046-020-01798-2
   PubMed Web of Science ®Google Scholar
• Seal RL, Chen LL, Griffiths-Jones S, et al. A guide to naming human non-coding RNA genes. EMBO J. 2020;39(6):e103777. doi:10.15252/embj.2019103777
   PubMed Web of Science ®Google Scholar
• Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. 2006;15:R17–29. doi:10.1093/hmg/ddl046
   PubMed Web of Science ®Google Scholar
• Gao L, Jiang Z, Han Y, Li Y, Yang X. Regulation of Pyroptosis by ncRNA: a Novel Research Direction. Front Cell Dev Biol. 2022;10:840576. doi:10.3389/fcell.2022.840576
   PubMed Web of Science ®Google Scholar
• Cao Z, Huang D, Tang C, et al. Pyroptosis in diabetes and diabetic nephropathy. Clin Chim Acta. 2022;531:188–196. doi:10.1016/j.cca.2022.04.011
   PubMed Web of Science ®Google Scholar
• Gao J, Chen X, Wei P, Wang Y, Li P, Shao K. Regulation of pyroptosis in cardiovascular pathologies: role of noncoding RNAs. Mol Ther Nucleic Acids. 2021;25:220–236. doi:10.1016/j.omtn.2021.05.016
   PubMedGoogle Scholar
• Yuan Y, Xu L, Geng Z, et al. The role of non-coding RNA network in atherosclerosis. Life Sci. 2021;265:118756. doi:10.1016/j.lfs.2020.118756
   PubMed Web of Science ®Google Scholar
• Zhang M, Dang P, Liu Y, Qiao B, Sun Z. Noncoding RNAs in pyroptosis and cancer progression: effect, mechanism, and clinical application. Front Immunol. 2022;13:982040. doi:10.3389/fimmu.2022.982040
   PubMed Web of Science ®Google Scholar
• Sansonetti PJ, Phalipon A, Arondel J, et al. Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity. 2000;12(5):581–590. doi:10.1016/s1074-7613(00)80209-5
   PubMed Web of Science ®Google Scholar
• Li P, Allen H, Banerjee S, et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell. 1995;80(3):401–411. doi:10.1016/0092-8674(95)90490-5
   PubMed Web of Science ®Google Scholar
• Hersh D, Monack DM, Smith MR, Ghori N, Falkow S, Zychlinsky A. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci U S A. 1999;96(5):2396–2401. doi:10.1073/pnas.96.5.2396
   PubMed Web of Science ®Google Scholar
• Monack DM, Detweiler CS, Falkow S. Salmonella pathogenicity island 2-dependent macrophage death is mediated in part by the host cysteine protease caspase-1. Cell Microbiol. 2001;3(12):825–837. doi:10.1046/j.1462-5822.2001.00162.x
   PubMed Web of Science ®Google Scholar
• Amarante-Mendes GP, Adjemian S, Branco LM, Zanetti LC, Weinlich R, Bortoluci KR. Pattern Recognition Receptors and the Host Cell Death Molecular Machinery. Front Immunol. 2018;9:2379. doi:10.3389/fimmu.2018.02379
   PubMed Web of Science ®Google Scholar
• Liao Z, Su J. Progresses on three pattern recognition receptor families (TLRs, RLRs and NLRs) in teleost. Dev Comp Immunol. 2021;122:104131. doi:10.1016/j.dci.2021.104131
   PubMed Web of Science ®Google Scholar
• Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13(2):148–159. doi:10.1038/cmi.2015.95
   PubMed Web of Science ®Google Scholar
• Ozaki E, Campbell M, Doyle SL. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. J Inflamm Res. 2015;8:15–27. doi:10.2147/JIR.S51250
   PubMed Web of Science ®Google Scholar
• Cao H, Yang D, Nie K, et al. Hesperidin may improve depressive symptoms by binding NLRP3 and influencing the pyroptosis pathway in a rat model. Eur J Pharmacol. 2023;952:175670. doi:10.1016/j.ejphar.2023.175670
   PubMed Web of Science ®Google Scholar
• Zhou S, Li Y, Hong Y, Zhong Z, Zhao M. Puerarin protects against sepsis-associated encephalopathy by inhibiting NLRP3/Caspase-1/GSDMD pyroptosis pathway and reducing blood-brain barrier damage. Eur J Pharmacol. 2023;945:175616. doi:10.1016/j.ejphar.2023.175616
   PubMed Web of Science ®Google Scholar
• Liu Y, Shu J, Liu T, et al. Nicorandil protects against coronary microembolization-induced myocardial injury by suppressing cardiomyocyte pyroptosis via the AMPK/TXNIP/NLRP3 signaling pathway. Eur J Pharmacol. 2022;936:175365. doi:10.1016/j.ejphar.2022.175365
   PubMed Web of Science ®Google Scholar
• Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18(9):2114–2127. doi:10.1038/s41423-021-00740-6
   PubMed Web of Science ®Google Scholar
• Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature. 2012;481(7381):278–286. doi:10.1038/nature10759
   PubMed Web of Science ®Google Scholar
• Liston A, Masters SL. Homeostasis-altering molecular processes as mechanisms of inflammasome activation. Nat Rev Immunol. 2017;17(3):208–214. doi:10.1038/nri.2016.151
   PubMed Web of Science ®Google Scholar
• Jin Y, Li H, Xie G, Chen S, Wu S, Fang X. Sevoflurane combined with ATP activates caspase-1 and triggers caspase-1-dependent pyroptosis in murine J774 macrophages. Inflammation. 2013;36(2):330–336. doi:10.1007/s10753-012-9550-6
   PubMed Web of Science ®Google Scholar
• Jorgensen I, Miao EA. Pyroptotic cell death defends against intracellular pathogens. Immunol Rev. 2015;265(1):130–142. doi:10.1111/imr.12287
   PubMed Web of Science ®Google Scholar
• Vanaja SK, Russo AJ, Behl B, et al. Bacterial Outer Membrane Vesicles Mediate Cytosolic Localization of LPS and Caspase-11 Activation. Cell. 2016;165(5):1106–1119. doi:10.1016/j.cell.2016.04.015
   PubMed Web of Science ®Google Scholar
• Gao YL, Zhai JH, Chai YF. Recent Advances in the Molecular Mechanisms Underlying Pyroptosis in Sepsis. Mediators Inflamm. 2018;2018:5823823. doi:10.1155/2018/5823823
   PubMed Web of Science ®Google Scholar
• Zhao Y, Shi J, Shao F. Inflammatory Caspases: activation and Cleavage of Gasdermin-D In Vitro and During Pyroptosis. Methods Mol Biol. 2018;1714:131–148. doi:10.1007/978-1-4939-7519-8_9
   PubMedGoogle Scholar
• Feng S, Fox D, Man SM. Mechanisms of Gasdermin Family Members in Inflammasome Signaling and Cell Death. J Mol Biol. 2018;430(18 Pt B):3068–3080. doi:10.1016/j.jmb.2018.07.002
   PubMed Web of Science ®Google Scholar
• Xia W, Li Y, Wu M, et al. Gasdermin E deficiency attenuates acute kidney injury by inhibiting pyroptosis and inflammation. Cell Death Dis. 2021;12(2):139. doi:10.1038/s41419-021-03431-2
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao W, Shi X, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547(7661):99–103. doi:10.1038/nature22393
   PubMed Web of Science ®Google Scholar
• Vince JE, Silke J. The intersection of cell death and inflammasome activation. Cell Mol Life Sci. 2016;73(11–12):2349–2367. doi:10.1007/s00018-016-2205-2
   PubMed Web of Science ®Google Scholar
• Chen KW, Demarco B, Heilig R, et al. Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly. EMBO J. 2019;38(10):e101638. doi:10.15252/embj.2019101638
   PubMed Web of Science ®Google Scholar
• Newton K, Wickliffe KE, Maltzman A, et al. Activity of caspase-8 determines plasticity between cell death pathways. Nature. 2019;575:679–682. doi:10.1038/s41586-019-1752-8
   PubMed Web of Science ®Google Scholar
• Hou J, Zhao R, Xia W, et al. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol. 2020;22(10):1264–1275. doi:10.1038/s41556-020-0575-z
   PubMed Web of Science ®Google Scholar
• Orning P, Weng D, Starheim K, et al. Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death. Science. 2018;362(6418):1064–1069. doi:10.1126/science.aau2818
   PubMed Web of Science ®Google Scholar
• Hernandez C, Huebener P, Pradere JP, Antoine DJ, Friedman RA, Schwabe RF. HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis. J Clin Invest. 2018;128(6):2436–2451. doi:10.1172/JCI91786
   PubMed Web of Science ®Google Scholar
• Wu Y, Qiu G, Zhang H, et al. Dexmedetomidine alleviates hepatic ischaemia-reperfusion injury via the PI3K/AKT/Nrf2-NLRP3 pathway. J Cell Mol Med. 2021;25(21):9983–9994. doi:10.1111/jcmm.16871
   PubMed Web of Science ®Google Scholar
• Chen X, Liu B, Li X, et al. Identification of anti-inflammatory vesicle-like nanoparticles in honey. J Extracell Vesicles. 2021;10(4):e12069. doi:10.1002/jev2.12069
   PubMed Web of Science ®Google Scholar
• Li F, Zhang L, Xue H, Xuan J, Rong S, Wang K. SIRT1 alleviates hepatic ischemia-reperfusion injury via the miR-182-mediated XBP1/NLRP3 pathway. Mol Ther Nucleic Acids. 2021;23:1066–1077. doi:10.1016/j.omtn.2020.11.015
   PubMedGoogle Scholar
• Du C, Song H, Wang X, Wang Z. miR-182-5p regulates pyroptosis involving liver ischemia reperfusion injury. Tianjin Med J. 2018;46(10):1045–1050. doi:10.11958/20180682
   Google Scholar
• Li S, Zhu Z, Sun L, Zhang H. Effect of miR-330-3p on hepatic ischemia-reperfusion injury in mice. Chin J Hepatobiliary Surg. 2021;27(5):371–376. doi:10.3760/cma.j.cn113884-20200915-00491
   Google Scholar
• Yang L, Tian L, Zhang Z, et al. Cannabinoid Receptor 1/miR-30b-5p Axis Governs Macrophage NLRP3 Expression and Inflammasome Activation in Liver Inflammatory Disease. Mol Ther Nucleic Acids. 2020;20:725–738. doi:10.1016/j.omtn.2020.04.010
   PubMedGoogle Scholar
• Chang H, Chang H, Cheng T, Lee GD, Chen X, Qi K. Micro-ribonucleic acid-23a-3p prevents the onset of type 2 diabetes mellitus by suppressing the activation of nucleotide-binding oligomerization-like receptor family pyrin domain containing 3 inflammatory bodies-caused pyroptosis through negatively regulating NIMA-related kinase 7. J Diabetes Investig. 2021;12(3):334–345. doi:10.1111/jdi.13396
   PubMed Web of Science ®Google Scholar
• Chen L, Lu FB, Chen DZ, et al. BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis. Mol Immunol. 2018;93:38–46. doi:10.1016/j.molimm.2017.11.008
   PubMed Web of Science ®Google Scholar
• Yue Y, Du Z, Tao J, Shi L. Inhibition of microRNA-297 alleviates THLE-2 cell injury induced by hypoxia/reoxygenation by inhibiting NLRP3 inflammasome activation via sirtuin 3. Can J Physiol Pharmacol. 2022;100(2):125–133. doi:10.1139/cjpp-2021-0287
   PubMed Web of Science ®Google Scholar
• Menon MP, Hua KF. The Long Non-coding RNAs: paramount Regulators of the NLRP3 Inflammasome. Front Immunol. 2020;11:569524. doi:10.3389/fimmu.2020.569524
   PubMed Web of Science ®Google Scholar
• Liang C, Peng Y, Sun H, Wang L, Jiang L, Zou S. Silencing lncRNA KCNQ1OT1 reduced hepatic ischemia reperfusion injury-induced pyroptosis by regulating miR-142a-3p/HMGB1 axis. Mol Cell Biochem. 2022. doi:10.1007/s11010-022-04586-y
   Web of Science ®Google Scholar
• Chen Z, Jia S, Li D, et al. Silencing of long noncoding RNA AK139328 attenuates ischemia/reperfusion injury in mouse livers. PLoS One. 2013;8(11):e80817. doi:10.1371/journal.pone.0080817
   PubMed Web of Science ®Google Scholar
• Brocker CN, Kim D, Melia T, et al. Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting. Nat Commun. 2020;11(1):5847. doi:10.1038/s41467-020-19554-7
   PubMed Web of Science ®Google Scholar
• Oakley F. Interrogating mechanisms of liver fibrosis with omics. Nat Rev Gastroenterol Hepatol. 2022;19(2):89–90. doi:10.1038/s41575-021-00567-6
   PubMed Web of Science ®Google Scholar
• Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27–42. doi:10.1016/j.addr.2017.05.007
   PubMed Web of Science ®Google Scholar
• Du G, Wang J, Zhang T, et al. Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo. Cell Death Dis. 2020;11(2):118. doi:10.1038/s41419-020-2229-2
   PubMed Web of Science ®Google Scholar
• Jimenez Calvente C, Del Pilar H, Tameda M, Johnson CD, Feldstein AE. MicroRNA 223 3p Negatively Regulates the NLRP3 Inflammasome in Acute and Chronic Liver Injury. Mol Ther. 2020;28(2):653–663. doi:10.1016/j.ymthe.2019.09.013
   PubMed Web of Science ®Google Scholar
• Calvente CJ, Tameda M, Johnson CD, et al. Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223. J Clin Invest. 2019;129(10):4091–4109. doi:10.1172/JCI122258
   PubMed Web of Science ®Google Scholar
• Li J, Xue J, Wang D, et al. Regulation of gasdermin D by miR-379-5p is involved in arsenite-induced activation of hepatic stellate cells and in fibrosis via secretion of IL-1β from human hepatic cells. Metallomics. 2019;11(2):483–495. doi:10.1039/c8mt00321a
   PubMed Web of Science ®Google Scholar
• Ning ZW, Luo XY, Wang GZ, et al. MicroRNA-21 Mediates Angiotensin II-Induced Liver Fibrosis by Activating NLRP3 Inflammasome/IL-1β Axis via Targeting Smad7 and Spry1. Antioxid Redox Signal. 2017;27(1):1–20. doi:10.1089/ars.2016.6669
   PubMed Web of Science ®Google Scholar
• Zhang K, Shi Z, Zhang M, et al. Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis. Cell Death Dis. 2020;11(2):132. doi:10.1038/s41419-020-2323-5
   PubMed Web of Science ®Google Scholar
• Yang L, Fu WL, Zhu Y, Wang XG. Tβ4 suppresses lincRNA-p21-mediated hepatic apoptosis and fibrosis by inhibiting PI3K-AKT-NF-κB pathway. Gene. 2020;758:144946. doi:10.1016/j.gene.2020.144946
   PubMed Web of Science ®Google Scholar
• Wang R, Li S, Chen P, et al. Salvianolic acid B suppresses hepatic stellate cell activation and liver fibrosis by inhibiting the NF-κB signaling pathway via miR-6499-3p/LncRNA-ROR. Phytomedicine. 2022;107:154435. doi:10.1016/j.phymed.2022.154435
   PubMed Web of Science ®Google Scholar
• Su SB, Tao L, Liang XL, Chen W. Long noncoding RNA GAS5 inhibits LX-2 cells activation by suppressing NF-κB signalling through regulation of the miR-433-3p/TLR10 axis. Dig Liver Dis. 2022;54(8):1066–1075. doi:10.1016/j.dld.2021.11.002
   PubMedGoogle Scholar
• Hyun J, Han J, Lee C, Yoon M, Jung Y. Pathophysiological Aspects of Alcohol Metabolism in the Liver. Int J Mol Sci. 2021;22(11):5717. doi:10.3390/ijms22115717
   PubMed Web of Science ®Google Scholar
• Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. 2015;12(4):231–242. doi:10.1038/nrgastro.2015.35
   PubMed Web of Science ®Google Scholar
• Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908–922. doi:10.1038/s41591-018-0104-9
   PubMed Web of Science ®Google Scholar
• Kolodziejczyk AA, Zheng D, Shibolet O, Elinav E. The role of the microbiome in NAFLD and NASH. EMBO Mol Med. 2019;11(2):e9302. doi:10.15252/emmm.201809302
   PubMed Web of Science ®Google Scholar
• Ajmera V, Loomba R. Imaging biomarkers of NAFLD, NASH, and fibrosis. Mol Metab. 2021;50:101167. doi:10.1016/j.molmet.2021.101167
   PubMed Web of Science ®Google Scholar
• Ganz M, Csak T, Szabo G. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation. World J Gastroenterol. 2014;20(26):8525–8534. doi:10.3748/wjg.v20.i26.8525
   PubMed Web of Science ®Google Scholar
• Beier JI, Banales JM. Pyroptosis: an inflammatory link between NAFLD and NASH with potential therapeutic implications. J Hepatol. 2018;68(4):643–645. doi:10.1016/j.jhep.2018.01.017
   PubMed Web of Science ®Google Scholar
• Henao-Mejia J, Elinav E, Jin C, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482:179–185. doi:10.1038/nature10809
   PubMed Web of Science ®Google Scholar
• Petrasek J, Iracheta-Vellve A, Saha B, et al. Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease. J Leukoc Biol. 2015;98(2):249–256. doi:10.1189/jlb.3AB1214-590R
   PubMed Web of Science ®Google Scholar
• Bala S, Ganz M, Babuta M, et al. Steatosis, inflammasome upregulation, and fibrosis are attenuated in miR-155 deficient mice in a high fat-cholesterol-sugar diet-induced model of NASH. Lab Invest. 2021;101(12):1540–1549. doi:10.1038/s41374-021-00626-1
   PubMed Web of Science ®Google Scholar
• Chen X, Xue W, Zhang J, Peng J, Huang W. Ginsenoside Rg1 attenuates the NASH phenotype by regulating the miR-375-3p/ATG2B/PTEN-AKT axis to mediate autophagy and pyroptosis. Lipids Health Dis. 2023;22(1):22. doi:10.1186/s12944-023-01787-2
   PubMed Web of Science ®Google Scholar
• Pan XS, Li BW, Wang LL, et al. Kupffer cell pyroptosis mediated by METTL3 contributes to the progression of alcoholic steatohepatitis. FASEB J. 2023;37(6):e22965. doi:10.1096/fj.202300059RR
   PubMed Web of Science ®Google Scholar
• Heo MJ, Kim TH, You JS, Blaya D, Sancho-Bru P, Kim SG. Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression. Gut. 2019;68(4):708–720. doi:10.1136/gutjnl-2017-315123
   PubMed Web of Science ®Google Scholar
• Lin Y, Wang S, Gao L, et al. Oscillating lncRNA Platr4 regulates NLRP3 inflammasome to ameliorate nonalcoholic steatohepatitis in mice. Theranostics. 2021;11(1):426–444. doi:10.7150/thno.50281
   PubMed Web of Science ®Google Scholar
• Chen T, Meng Y, Zhou Z, et al. GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis. Cell Death Differ. 2023;30(7):1829–1848. doi:10.1038/s41418-023-01183-4
   PubMed Web of Science ®Google Scholar
• Chu Q, Jiang Y, Zhang W, et al. Pyroptosis is involved in the pathogenesis of human hepatocellular carcinoma. Oncotarget. 2016;7(51):84658–84665. doi:10.18632/oncotarget.12384
   PubMedGoogle Scholar
• Wei Q, Mu K, Li T, et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest. 2014;94(1):52–62. doi:10.1038/labinvest.2013.126
   PubMed Web of Science ®Google Scholar
• Wei Q, Zhu R, Zhu J, Zhao R, Li M. E2-Induced Activation of the NLRP3 Inflammasome Triggers Pyroptosis and Inhibits Autophagy in HCC Cells. Oncol Res. 2019;27(7):827–834. doi:10.3727/096504018X15462920753012
   PubMed Web of Science ®Google Scholar
• Du C, Song H, Wang X, Wang Z. MiRNA-30a-3p inhibits proliferation and metastasis of hepatocellular carcinoma cells by regulating caspase 1-mediated pyroptosis. Chinese J of General Sur. 2018;33(11):920–923. doi:10.3760/cma.j.issn.1007-631X.2018.11.007
   Google Scholar
• Chen Z, He M, Chen J, Li C, Zhang Q. Long non-coding RNA SNHG7 inhibits NLRP3-dependent pyroptosis by targeting the miR-34a/SIRT1 axis in liver cancer. Oncol Lett. 2020;20(1):893–901. doi:10.3892/ol.2020.11635
   PubMed Web of Science ®Google Scholar
• Schwabe RF, Luedde T. Apoptosis and necroptosis in the liver: a matter of life and death. Nat Rev Gastroenterol Hepatol. 2018;15(12):738–752. doi:10.1038/s41575-018-0065-y
   PubMed Web of Science ®Google Scholar
• Harakeh S, Saber SH, Al-Raddadi R, et al. Novel curcumin nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells. Artif Cells Nanomed Biotechnol. 2023;51(1):361–370. doi:10.1080/21691401.2023.2238756
   PubMed Web of Science ®Google Scholar
• Mai W, Xu Y, Xu J, et al. Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis. Front Pharmacol. 2020;11:185. doi:10.3389/fphar.2020.00185
   PubMed Web of Science ®Google Scholar
• Shi H, Qiao F, Lu W, et al. Baicalin improved hepatic injury of NASH by regulating NRF2/HO-1/NRLP3 pathway. Eur J Pharmacol. 2022;934:175270. doi:10.1016/j.ejphar.2022.175270
   PubMed Web of Science ®Google Scholar
• Ye H, Ma S, Qiu Z, et al. Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis. J Ethnopharmacol. 2022;296:115457. doi:10.1016/j.jep.2022.115457
   PubMed Web of Science ®Google Scholar
• Han H, Li J, Tian L, Pei L, Zheng M. Through regulation of the SIRT1 pathway plant sterol ester of α-linolenic acid inhibits pyroptosis thereby attenuating the development of NASH in mice. J Nutr Biochem. 2023;119:109408. doi:10.1016/j.jnutbio.2023.109408
   PubMed Web of Science ®Google Scholar
• Song A, Ding T, Wei N, et al. Schisandrin B induces HepG2 cells pyroptosis by activating NK cells mediated anti-tumor immunity. Toxicol Appl Pharmacol. 2023;472:116574. doi:10.1016/j.taap.2023.116574
   PubMed Web of Science ®Google Scholar
• Qin L, Chen Y, Huang G, Wu R, Liu D. Effects of Isodon ternifolius extract on TLR4/NF-κB/NLRP3 pathway in hepatic stellate cells and hepatocytes. China Pharm. 2022;33(20):2448–2453. doi:10.6039/j.issn.1001-0408.2022.20.04
   Google Scholar
• Huang GD, Zhou ZP, Pang Z, et al. Effect of Isodon ternifolius-medicated serum on hepatic stellate cells based on TLR4/NF-κB/NLRP3 signaling pathway. Zhongguo Zhong Yao Za Zhi. 2023;48(14):3913–3921. doi:10.19540/j.cnki.cjcmm.20230306.704
   PubMedGoogle Scholar
• Leung LK, Su Y, Chen R, Zhang Z, Huang Y, Chen ZY. Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr. 2001;131(9):2248–2251. doi:10.1093/jn/131.9.2248
   PubMed Web of Science ®Google Scholar
• Cai X, Liu Z, Dong X, et al. Hypoglycemic and lipid lowering effects of theaflavins in high-fat diet-induced obese mice. Food Funct. 2021;12(20):9922–9931. doi:10.1039/d1fo01966j
   PubMed Web of Science ®Google Scholar
• Alam M, Ali S, Ashraf GM, Bilgrami AL, Yadav DK, Hassan MI. Epigallocatechin 3-gallate: from green tea to cancer therapeutics. Food Chem. 2022;379:132135. doi:10.1016/j.foodchem.2022.132135
   PubMed Web of Science ®Google Scholar
• Yussof A, Cammalleri B, Fayemiwo O, Lopez S, Chu T. Antibacterial and Sporicidal Activity Evaluation of Theaflavin-3,3’-digallate. Int J Mol Sci. 2022;23(4):2153. doi:10.3390/ijms23042153
   PubMed Web of Science ®Google Scholar
• Cao Y, Zhang Y, Jia Z, et al. Theaflavin-3,3’-digallate ameliorates learning and memory impairments in mice with premature brain aging induced by D-galactose. Physiol Behav. 2023;261:114077. doi:10.1016/j.physbeh.2023.114077
   PubMed Web of Science ®Google Scholar
• Zhang G, Fu H, Zou Y, Deng Z. Effects of theaflavin-3,3’-digallate on high-fat diet-induced liver injury in mice and its mechanism. J Third Military Med Univ. 2022;44(2):147–154. doi:10.16016/j.2097-0927.202107051
   Google Scholar
• Zhao XJ, Yu HW, Yang YZ, et al. Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway. Redox Biol. 2018;18:124–137. doi:10.1016/j.redox.2018.07.002
   PubMed Web of Science ®Google Scholar
• Ding XQ, Wu WY, Jiao RQ, et al. Curcumin and allopurinol ameliorate fructose-induced hepatic inflammation in rats via miR-200a-mediated TXNIP/NLRP3 inflammasome inhibition. Pharmacol Res. 2018;137:64–75. doi:10.1016/j.phrs.2018.09.021
   PubMed Web of Science ®Google Scholar
• Gao Q, Li G, Zu Y, et al. Ginsenoside Rg1 alleviates ANIT-induced cholestatic liver injury by inhibiting hepatic inflammation and oxidative stress via SIRT1 activation. J Ethnopharmacol. 2023;319(Pt 1):117089. doi:10.1016/j.jep.2023.117089
   PubMedGoogle Scholar
• Hsieh CC, Chang CY, Yar Lee TX, et al. Longevity, tumor, and physical vitality in rats consuming ginsenoside Rg1. J Ginseng Res. 2023;47(2):210–217. doi:10.1016/j.jgr.2021.04.006
   PubMed Web of Science ®Google Scholar
• Wang Z, Du K, Hou J, et al. Rg1 alleviates oxidative stress and spermatogonium apoptosis in D-gal-induced testicular toxicity by activating Akt. Redox Rep. 2023;28(1):2206197. doi:10.1080/13510002.2023.2206197
   PubMed Web of Science ®Google Scholar
• Yang L, Yu H, Hou A, et al. A Review of the Ethnopharmacology, Phytochemistry, Pharmacology, Application, Quality Control, Processing, Toxicology, and Pharmacokinetics of the Dried Rhizome of Atractylodes macrocephala. Front Pharmacol. 2021;12:727154. doi:10.3389/fphar.2021.727154
   PubMed Web of Science ®Google Scholar
• Guo S, Li W, Chen F, et al. Polysaccharide of Atractylodes macrocephala Koidz regulates LPS-mediated mouse hepatitis through the TLR4-MyD88-NFκB signaling pathway. Int Immunopharmacol. 2021;98:107692. doi:10.1016/j.intimp.2021.107692
   PubMed Web of Science ®Google Scholar
• Chen F, Li B, Li W, et al. Polysaccharide of Atractylodes macrocephala Koidz alleviate lipopolysaccharide-stimulated liver inflammation injury of goslings through miR-223/NLRP3 axis. Poult Sci. 2023;102(1):102285. doi:10.1016/j.psj.2022.102285
   PubMed Web of Science ®Google Scholar
• Gür FM, Bilgiç S. Silymarin, an antioxidant flavonoid, protects the liver from the toxicity of the anticancer drug paclitaxel. Tissue Cell. 2023;83:102158. doi:10.1016/j.tice.2023.102158
   PubMed Web of Science ®Google Scholar
• Tang S, Zhang X, Duan Z, et al. The novel hepatoprotective mechanisms of silibinin-phospholipid complex against d-GalN/LPS-induced acute liver injury. Int Immunopharmacol. 2023;116:109808. doi:10.1016/j.intimp.2023.109808
   PubMed Web of Science ®Google Scholar
• Li ZY, Hao EW, Du ZC, et al. Research progress of Curcuma kwangsiensis root tubers and analysis of liver protection and anti-tumor mechanisms based on Q-markers. Zhongguo Zhong Yao Za Zhi. 2022;47(7):1739–1753. doi:10.19540/j.cnki.cjcmm.20211220.203
   PubMedGoogle Scholar
• Sun S, Huan S, Li Z, et al. Curcumol alleviates liver fibrosis by inducing endoplasmic reticulum stress-mediated necroptosis of hepatic stellate cells through Sirt1/NICD pathway. PeerJ. 2022;10:e13376. doi:10.7717/peerj.13376
   PubMed Web of Science ®Google Scholar
• Wang J, Guo X, Zheng B, Liang X. Mechanism of curcumol against liver fibrosis based on miR-125b/NLRP3 signaling pathway. Chinese Archives Traditional Chin Med. 2022;40(11):95–99. doi:10.13193/j.issn.1673-7717.2022.11.023
   Google Scholar
• Liu X, Lv M, Wang Y, et al. Anti-depressive effects of Xiaoyaosan, Shugan and Jianpi herbal treatments: role on the gut microbiome of CUMS rats. Phytomedicine. 2021;87:153581. doi:10.1016/j.phymed.2021.153581
   PubMed Web of Science ®Google Scholar
• Fan C. Mechanism of Lnc ECONEXIN/miR-26-b-5p/TLR4 signal axis promotes the activation of HSC by regulating pyroptosis and the intervention effect of Shugan Jianpi formula. Anhui Univ Chine Med. 2023. doi:10.26922/d.cnki.ganzc.2022.000320
   Google Scholar
• Wang Y, Wang X, Jiang K, Yang K, Ling J. Network pharmacology and experimental studies for deciphering the molecular targets and mechanisms of Chaihu Shugan powder in the treatment of functional dyspepsia. Technol Health Care. 2023;31(S1):449–462. doi:10.3233/THC-236039
   PubMedGoogle Scholar
• Jia KK, Pan SM, Ding H, et al. Chaihu-shugan san inhibits inflammatory response to improve insulin signaling in liver and prefrontal cortex of CUMS rats with glucose intolerance. Biomed Pharmacother. 2018;103:1415–1428. doi:10.1016/j.biopha.2018.04.171
   PubMed Web of Science ®Google Scholar
• Inzaugarat ME, Johnson CD, Holtmann TM, et al. NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice. Hepatology. 2019;69(2):845–859. doi:10.1002/hep.30252
   PubMed Web of Science ®Google Scholar
• Wang BE. Treatment of chronic liver diseases with traditional Chinese medicine. J Gastroenterol Hepatol. 2000;15 Suppl:E67–70. doi:10.1046/j.1440-1746.2000.02100.x
   PubMed Web of Science ®Google Scholar
• Chen M, Xie Y, Gong S, et al. Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis. Pharmacol Res. 2021;172:105849. doi:10.1016/j.phrs.2021.105849
   PubMed Web of Science ®Google Scholar